Immunotherapies for cancer reviewed

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1432-1433, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Prostate Cancer Immunotherapies

By Basler Michael Groettrup Marcus

Drugs & Aging, Vol. 24, Iss. 3, 2007-01 ,pp. : 197-221

Adis International

Access to resources Recommend Favorite

Cancer immunotherapies, their safety and toxicity

By Alatrash Gheath Jakher Haroon Stafford Patricia D Mittendorf Elizabeth A

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 631-645

Informa Healthcare

Access to resources Recommend Favorite

Emerging Immunotargets and Immunotherapies in Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. : 777-782

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of advanced colorectal cancer reviewed

Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

Current Cancer Drug Targets, Vol. 16, Iss. 9, 2016-10 ,pp. : 755-764

Bentham Science Publishers

Access to resources Recommend Favorite